The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival.
Open accessAbstract
Although anatomical barriers and soluble mediators have been implicated in immune privilege, it appears that the apoptotic cell death of Fas+ cells by tissue-associated CD95 ligand (Fas ligand, FasL) is an important component. One clinical example of the function of an immune privileged site is the success of human corneal transplants, where a very high percentage of transplants accept without tissue matching or immunosuppressive therapy. Since the mouse cornea expresses abundant Fas ligand and immune privilege has been implicated in the success of these transplants, we examined the role of FasL in corneal transplantation. Our results show that human corneas express functional FasL capable of killing Fas+ lymphoid cells in an in vitro culture system. Using a mouse model for corneal allograft transplantation, FasL+ orthografts were accepted at a rate of 45%, whereas FasL- grafts, or normal grafts transplanted to Fas- mice, were rejected 100% of the time. Histological analysis found that FasL+ grafts contained apoptotic mononuclear cells indicating the induction of apoptosis by the graft, while rejecting FasL- corneas contained numerous inflammatory cells without associated apoptosis. Taken together our results demonstrate that FasL expression on the cornea is a major factor in corneal allograft survival and, thus, we provide an explanation for one of the most successful tissue transplants performed in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Self-citationFas(CD95)/FasL interactions required for programmed cell death after T-cell activation
Ju, S.-T., Panka, D. J., Cui, H., Ettinger, R., EI-Khatib, M., Sherr, D. H., Stanger, B. Z., & Marshak-Rothstein, A. (1995) · Nature · doi:10.1038/373444a0 · Cited by 1,499
Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., et al. (1995) · Nature · doi:10.1038/373441a0 · Cited by 1,314
Mutations in Fas Associated with Human Lymphoproliferative Syndrome and Autoimmunity
Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A. G., Debatin, K. M., Fischer, A., & de Villartay, J. P. (1995) · Science · doi:10.1126/science.7539157 · Cited by 1,297
A role for CD95 ligand in preventing graft rejection
Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., & Duke, R. C. (1995) · Nature · doi:10.1038/377630a0 · Cited by 1,155
Fas and Fas ligand: lpr and gld mutations
Nagata, S., & Suda, T. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80069-7 · Cited by 892
Singer, G. G., & Abbas, A. K. (1994) · Immunity · doi:10.1016/1074-7613(94)90067-1 · Cited by 691
Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in Mice
Lau, H. T., Yu, M., Fontana, A., & Stoeckert, C. J. (1996) · Science · doi:10.1126/science.273.5271.109 · Cited by 445
CD95-Induced Apoptosis of Lymphocytes in an Immune Privileged Site Induces Immunological Tolerance
Griffith, T. S., Yu, X., Herndon, J. M., Green, D. R., & Ferguson, T. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80305-2 · Cited by 382
Self-citationDie and Let Live: Eliminating Dangerous Lymphocytes
Abbas, A. K. (1996) · Cell · doi:10.1016/s0092-8674(00)81042-9 · Cited by 237
Kaplan, H. J., & Streilein, J. W. (1977) · PubMed · Cited by 208
Risk Factors of Corneal Graft Failure
Boisjoly, H. M., Tourigny, R., Bazin, R., Laughrea, P. A., Dubè, I., Chamberland, G., Bernier, J., & Roy, R. (1993) · Ophthalmology · doi:10.1016/s0161-6420(93)31409-0 · Cited by 187
Conclusions of the corneal transplant follow up study
Vail, A., Gore, S. M., Bradley, B. A., Easty, D. L., Rogers, C. A., & Armitage, W. J. (1997) · British Journal of Ophthalmology · doi:10.1136/bjo.81.8.631 · Cited by 174
Regulation of contact hypersensitivity by interleukin 10.
Ferguson, T. A., Dube, P., & Griffith, T. S. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1597 · Cited by 165
Self-citationImpaired cell-mediated immunity in mice bearing healthy orthotopic corneal allografts
Sonoda, Y., & Streilein, J. W. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.5.1727 · Cited by 150
Wilbanks, G. A., Mammolenti, M., & Streilein, J. W. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.9.3018 · Cited by 143
Fas (CD95) participates in peripheral T cell deletion and associated apoptosis in vivo
Mogil, R. J., Radvanyi, L. G., González‐Quintial, R., Miller, R. G., Mills, G. B., Theofilopoulos, A. N., & Green, D. R. (1995) · International Immunology · doi:10.1093/intimm/7.9.1451 · Cited by 136
T-cell mediated responses in a murine model of orthotopic corneal transplantation.
Joo, C., Pepose, J. S., & Stuart, P. M. (1995) · PubMed · Cited by 91
Self-citationNeuropeptides modulate immune deviation induced via the anterior chamber of the eye
Ferguson, T. A., Fletcher, S., Herndon, J. M., & Griffith, T. S. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.1746 · Cited by 70
Self-citationFerguson, T. A., Hayashi, J. D., & Kaplan, H. J. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.3.821 · Cited by 42
Self-citationGriffith, T. S., Herndon, J. M., Lima, J., Kahn, M., Ferguson, T. A., & Ishizaka, K. (1995) · International Immunology · doi:10.1093/intimm/7.10.1617 · Cited by 28
Self-citationNiederkorn, J. Y., Callanan, D., & ROSS, J. R. (1990) · Transplantation · doi:10.1097/00007890-199008000-00023 · Cited by 22
Cited by
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2033 · Cited by 878
Ocular immune privilege: therapeutic opportunities from an experiment of nature
Streilein, J. W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1224 · Cited by 807
Nagata, S. (1999) · Annual Review of Genetics · doi:10.1146/annurev.genet.33.1.29 · Cited by 779
Activation‐induced cell death in T cells
Green, D. R., Droin, N., & Pinkoski, M. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00051.x · Cited by 647
Immune escape of tumors: apoptosis resistance and tumor counterattack
Igney, F. H., & Krammer, P. H. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.6.907 · Cited by 468
Metadata
- Authors
- Stuart, P. M., Griffith, T. S., Usui, N., Pepose, J., Yu, X., & Ferguson, T. A.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-02-01
- Volume
- 99
- Issue
- 3
- Pages
- 396-402
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1989400519
- Cited by
- 367
- References
- 22
- FWCI
- 40.81
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.